Herbal Medicine: Open Access

Recurrent vulvovaginal candidiasis: Clinical manifestations, pathogenesis and personalized therapeutics with homeopathic medicines

9^th International Conference on Acupuncture & Chinese Medicine
August 20-21, 2018 Dublin, Ireland

Vijay Nielsen

Nielsen Clinic, Canada

ScientificTracks Abstracts: Herb Med

DOI: 10.21767/2472-0151-C1-002

Abstract

Vulvovaginal candidiasis is one of the more common gynecological complaints seen in a healthcare setting and bears a significant financial, emotional and physical cost for women. It is estimated that upto 75% of women will experience one episode in their life, while 5-10% will have recurring episodes. For women who have three to four episodes within a year are diagnosed with recurrent vulvovaginal candidiasis. In the United States alone it is estimated that three million women suffer from Recurrent Vulvovaginal Candidiasis (RVVC). RVVC presents an increasing challenge in clinical practice due to increasing and widespread antifungal resistance. Experts have warned that the prevalence of vulvovaginitis will increase due to antifungal resistance and an expected rise in non C. albicans species. With increasing short course use of antifungal therapies and emergence of resistant yeast strains treating RVVC will present further challenges. Homeopathy may help to offer a simple, safe and cost-effective as clinical evidence as well as in vitro evidence has shown homeopathic medicines provide inhibitory activity against Candida albicans.

Biography

Vijay Nielsen has completed a Diploma in Homeopathic Medicine at Dr Nielsen’s Homeopathic Medical Education and Research Centre Inc., (Winnipeg, Canada) and has completed his fellowship at Vinayaka Mission’s Hospital (Salem, India). In 2005, he started his private practice at Nielsen Clinic, where he specializes in Women’s Health and Dermatology, combining homeopathy and integrative medicine with a clinical approach and has won numerous awards. He was recently selected as one of IMPACT Magazine’s Top Doctor for 2018. He is a Published Author in the Journal of Pharmacy & Pharmaceutical Sciences and has a amazon best seller co-authored book.

E-mail: vnielsen@nielsenclinic.com